INCY vs LRCX · P/E 14, rev $5.14B vs P/E 71, rev $23.23B
Incyte Corporation (INCY) versus Lam Research Corp (LRCX) — a side-by-side from cached financials, not a winner call.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ. It is led by Timothy M. Archer.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
INCY currently screens at market cap $20.45B and trailing P/E 14.5. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Not investment advice. Open the INCY and LRCX stock pages for the full models.
Not investment advice.